Valneva SE (VALN) Receivables - Net (2020 - 2026)
Valneva SE's (VALN) quarterly Receivables - Net came in at $11.9 million in Q1 2026, down 66.36% year-on-year from $35.3 million in Q1 2025, and down 63.36% quarter-over-quarter from $32.4 million in Q4 2025.
Valneva SE (VALN) Receivables - Net (2020 - 2026) Analysis & Trends
Valneva SE has disclosed Receivables - Net across 7 years of filings, most recently posting $11.9 million for Q1 2026.
- Receivables - Net for Q1 2026 came in at $11.9 million, down 66.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.9 million (down 66.36% YoY), and the FY2025 annual result was $32.4 million, down 13.94% from the prior year.
- Receivables - Net came in at $11.9 million for Q1 2026 at Valneva SE, down from $32.4 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $58.2 million in Q3 2022 to a low of $11.9 million in Q1 2026.
- The 5-year median for Receivables - Net is $32.4 million (2025), against an average of $32.4 million.
- Across the five-year window, Receivables - Net surged 111.43% in 2023 and slumped 66.36% in 2026, its largest moves.
- Valneva SE's Receivables - Net stood at $24.5 million in 2022, then soared by 83.02% to $44.8 million in 2023, then retreated by 16.04% to $37.6 million in 2024, then dropped by 13.94% to $32.4 million in 2025, then sank by 63.36% to $11.9 million in 2026.
- The last three Receivables - Net figures came in at $11.9 million (Q1 2026), $32.4 million (Q4 2025), and $23.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.86 Mn |
| Mar 31, 2026 | 11.86 Mn |
| Dec 31, 2025 | 32.38 Mn |
| Dec 31, 2025 | 32.38 Mn |
| Sep 30, 2025 | 23.47 Mn |
| Sep 30, 2025 | 23.47 Mn |
| Jun 30, 2025 | 27.31 Mn |
| Jun 30, 2025 | 27.31 Mn |
| Mar 31, 2025 | 35.26 Mn |
| Mar 31, 2025 | 35.26 Mn |
| Dec 31, 2024 | 37.62 Mn |
| Dec 31, 2024 | 37.62 Mn |
| Sep 30, 2024 | 33.34 Mn |
| Sep 30, 2024 | 33.34 Mn |
| Jun 30, 2024 | 32.87 Mn |
| Jun 30, 2024 | 32.87 Mn |
| Mar 31, 2024 | 29.64 Mn |
| Mar 31, 2024 | 29.64 Mn |
| Dec 31, 2023 | 44.81 Mn |
| Dec 31, 2023 | 44.81 Mn |